Clinical Trial Update: A Study of AL8326 in Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Clinical trial update for AL8326 in non-small cell lung cancer (Phase 1) shows the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AL8326

Snippet

Sponsor: Advenchen Laboratories, LLC | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING